Published

Psilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrug

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Acta Crystallographica Section E Crystallographic Communications
Date: 2021-02-01
Source: Crossref
DOI: 10.1107/s2056989021000116
PubMed: 33614134

Authors

Pham Duyen N. K.Chadeayne Andrew R.Golen James A.Manke David R.

Watch author

Derived topics and classifications

psilocin General Other

Citation graph

16 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

10.1089/jpm.2017.0684 10.1107/s2056989019007370 10.1107/s2414314619009623 10.1107/s2056989020002923 10.1107/s2056989020004077 10.1107/s2056989020008683 10.1021/acsomega.0c02208 10.9740/mhc.2017.01.024 10.1107/s0021889808042726 10.1021/acschemneuro.8b00186 10.1016/j.jchromb.2017.09.003 10.1055/s-1999-3490

Indexed papers citing this DOI

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 Psilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrug2021-02-01

Related papers

No close related records were found yet.